Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review

The aim is to evaluate the published evidence on whether methotrexate (MTX) use causes progressive fibrotic interstitial lung disease (fILD). This PRISMA-compliant systematic review has been registered electronically with PROSPERO 2018 ID CRD42018087838, Centre of review and dissemination at the Uni...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawson, Julie K., Quah, Edmond, Earnshaw, Ben, Amoasii, Constanta, Mudawi, Tareg, Spencer, Lisa G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079289/
https://www.ncbi.nlm.nih.gov/pubmed/33515067
http://dx.doi.org/10.1007/s00296-020-04773-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079289/
https://www.ncbi.nlm.nih.gov/pubmed/33515067
http://dx.doi.org/10.1007/s00296-020-04773-4

Ejemplares similares